4.7 Article

Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Novel drug developmental strategies for treatment-resistant depression

Eva Borbely et al.

Summary: This article reviews the treatment of major depressive disorder, focusing on overcoming treatment-resistant depression. Current clinical trials are investigating novel drug targets and candidates, including modulation of neurotransmission, opioidergic system, and hallucinogenic tryptamine derivatives. The only registered drug for treatment-resistant depression is the NMDA receptor antagonist, but combination therapies with other agents have also shown efficacy. Additionally, there is significant research being done on large-scale omics and neuroimaging studies, which may provide new insights into molecular mechanisms and potential therapeutic strategies.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Endocrinology & Metabolism

Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)

Annieke C. G. van Baar et al.

Summary: This study reports the long-term safety and efficacy of duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes. The results show that DMR leads to sustained improvements in insulin sensitivity and multiple metabolic parameters for up to 24 months post-treatment, without any serious adverse events or hypoglycemic events.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Pharmacology & Pharmacy

Perspectives for therapy of treatment-resistant depression

Mariusz Papp et al.

Summary: Treatment-resistant depression (TRD) presents a major challenge for mood disorder treatment, but novel treatments like deep brain stimulation and ketamine have shown promise in providing rapid relief for TRD sufferers.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Review Cell Biology

Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview

Enrique L. M. Ochoa

Summary: Lithium has neuroprotective properties in treating bipolar disorder, improving brain abnormalities through modulation of various mechanisms, but its specific targets and relationship with clinical efficacy are still unclear.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Association of antioxidant deficiency and the level of products of protein and lipid peroxidation in patients with the first episode of schizophrenia

Anna Sergeevna Piatoikina et al.

Summary: The study findings suggest that oxidative stress imbalance may be a pathogenetic link in schizophrenia, manifesting early in the course of the disease.

JOURNAL OF MOLECULAR NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Treatment resistance in psychiatry: state of the art and new directions

Oliver D. Howes et al.

Summary: Treatment resistance is a common issue in psychiatric disorders, leading to increased healthcare burden and costs. Despite growing research attention, there are significant gaps in understanding and addressing this issue, with key outstanding problems including heterogeneity and lack of consensus criteria. Recommendations for future research include harmonisation of definitions and exploration of novel interventions to improve targeted and personalised therapeutic approaches.

MOLECULAR PSYCHIATRY (2022)

Review Clinical Neurology

Update on the management of status epilepticus

Andrea O. Rossetti et al.

Summary: This review provides an updated assessment of pharmacological treatment for status epilepticus, with a focus on initial benzodiazepines underdosing and recent findings from the ESETT trial. It also highlights the increasing attention on status epilepticus in comatose survivors after cardiac arrest, where some patients may have a reasonably good prognosis. Further high-quality studies are needed to improve management strategies for patients with severe, refractory status epilepticus.

CURRENT OPINION IN NEUROLOGY (2021)

Article Obstetrics & Gynecology

Markers of human endometrial hypoxia can be detected in vivo and ex vivo during physiological menstruation

J. J. Reavey et al.

Summary: A prospective case study of 16 women with normal menstrual bleeding showed in vivo data supporting the presence of hypoxia in the menstrual endometrium, which may have implications for diagnosing and treating heavy menstrual bleeding.

HUMAN REPRODUCTION (2021)

Article Neurosciences

Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls

Yang Tian et al.

Summary: There was no significant difference in the prevalence of obesity between FEDN patients and the control group. BMI was positively associated with positive symptom severity in FEDN patients, along with higher levels of cholesterol, triglyceride, and other lipid parameters in obese patients.

PSYCHOPHARMACOLOGY (2021)

Review Psychiatry

Electroconvulsive Therapy in Mania: A Review of 80 Years of Clinical Experience

Alby Elias et al.

Summary: While electroconvulsive therapy (ECT) is no longer the first-line treatment for mania, recent research has shown promising results in its use, including the adoption of ultrabrief ECT, combination with pharmacological agents, and use as a maintenance strategy. Technical parameters, such as treatment frequency, electrode placements, and pulse width, play a critical role in its efficacy.

AMERICAN JOURNAL OF PSYCHIATRY (2021)

Review Psychology, Clinical

Treatment-resistant major depressive disorder: Canadian expert consensus on definition and assessment

Yuri E. Rybak et al.

Summary: The study aimed to reach a consensus on the concept, definition, staging model, and assessment of treatment-resistant depression (TRD). Experts recommended the use of staging models and clinical scales for evaluating depression, and identified risk factors and comorbidities as potential predictors for treatment resistance.

DEPRESSION AND ANXIETY (2021)

Article Pharmacology & Pharmacy

Antidepressants' effects on testosterone and estrogens: What do we know?

Pavlina Pavlidi et al.

Summary: Research has shown that sex hormones play a critical role in sex differences, impacting the efficacy and side effects of antidepressants. Most studies demonstrate an interaction between sex hormones and antidepressants in sexual function, behavior, and alleviating depressive symptoms. However, the majority of research focuses on male subjects, highlighting the need for further investigation into the effects of antidepressants on hormone levels in both males and females.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Menstrual Dysfunction in Women With Schizophrenia During Risperidone Maintenance Treatment

Qijing Bo et al.

Summary: This study found that about one-third of women with schizophrenia receiving maintenance risperidone treatment experience menstrual dysfunction. Risperidone dose is positively associated with menstrual dysfunction, and the severity of clinical symptoms is also related to menstrual dysfunction.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)

Article Endocrinology & Metabolism

High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report

Georg S. Kranz et al.

Summary: This study investigated the effects of gender-affirming hormone treatment on MAO-A levels in transgender individuals. Results showed significant reductions in MAO-A V-T in transmen under testosterone treatment, suggesting a potential role of testosterone in the pathogenesis and symptoms of depression, possibly through regulating serotonergic neurotransmission.

PSYCHONEUROENDOCRINOLOGY (2021)

Review Psychiatry

Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis

Annika Seppala et al.

Summary: This study analyzed whether baseline characteristics can predict treatment response in treatment-resistant schizophrenia, and found that only higher positive symptom score at baseline predicted a higher response percentage. The use of atypical antipsychotics, particularly clozapine, was associated with the greatest likelihood of response.

SCHIZOPHRENIA RESEARCH (2021)

Article Medicine, General & Internal

Abnormal Uterine Bleeding in Adolescents: A Multidisciplinary Approach

Ines Ramalho et al.

Summary: Abnormal uterine bleeding is a common reason for female adolescents to seek medical advice, impacting their quality of life significantly. Challenges in diagnosis and treatment arise from the lack of standardized care for adolescents. Early diagnosis and comprehensive treatment strategies are crucial in managing abnormal uterine bleeding.

ACTA MEDICA PORTUGUESA (2021)

Review Clinical Neurology

Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review

Frank M. C. Besag et al.

Summary: Adjunct aripiprazole is effective in reducing elevated serum prolactin levels and has a higher likelihood of normalising prolactin levels and improving related symptoms compared to adjunct placebo. Evidence suggests that adjunct aripiprazole may be effective in most patients based on case reports and open-label studies.

CNS DRUGS (2021)

Article Endocrinology & Metabolism

Obesity is associated with heavy menstruation that may be due to delayed endometrial repair

Jane J. Reavey et al.

Summary: Obesity is associated with increased menstrual blood loss in women. Mice on a high-fat diet showed delayed endometrial repair during menstruation, serving as a model for studying the impact of obesity on menstrual physiology. Obesity results in a more pro-inflammatory local endometrial environment at menstruation, potentially delaying endometrial repair and increasing menstrual blood loss.

JOURNAL OF ENDOCRINOLOGY (2021)

Article Dentistry, Oral Surgery & Medicine

Point-of-Care Pregnancy Testing in Outpatient Sedation Anesthesia: Experience from an Urban Hospital-Based Oral and Maxillofacial Surgery Clinic

William Konicki et al.

Summary: Pre-surgical POC pregnancy testing is common in US hospitals for women of child-bearing age, but less so in ambulatory care settings. A retrospective review of an outpatient oral and maxillofacial surgery clinic found that 2.8% of women undergoing procedures under intravenous sedation had elevated hCG levels suggestive of pregnancy. The cost to identify a single pregnancy in the study was $70.40.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2021)

Review Medicine, Research & Experimental

Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression (Review)

Simona Trifu et al.

Summary: Electroconvulsive therapy (ECT) is an effective treatment for severe depression, despite its history of stigma and controversy. The combination of ECT technique with standard medication and care can improve patient outcomes. However, there is currently limited statistical evidence due to a small number of studies on ECT.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Cell Biology

Acute Valproate Exposure Induces Mitochondrial Biogenesis and Autophagy with FOXO3a Modulation in SH-SY5Y Cells

Eun-Hye Jang et al.

Summary: In this study, we found that treatment with valproic acid induced mitochondrial biogenesis and autophagy in the SH-SY5Y cell line by altering FOXO3a expression and posttranslational modification.

CELLS (2021)

Article Medicine, General & Internal

Pictorial Blood Loss Assessment Chart for evaluating heavy menstrual bleeding in Asian women

Jennifer K. Y. Ko et al.

Summary: The study demonstrates that the PBAC can effectively differentiate self-perceived heavy and normal menstrual bleeding in Asian women in Hong Kong, serving as an additional indicator to alert women to seek early medical attention.

HONG KONG MEDICAL JOURNAL (2021)

Article Medicine, General & Internal

Depression and Its Effect on the Menstrual Cycle

Jaskamal Padda et al.

Summary: There is a strong association between depression and early perimenopause as well as menopause, especially in women with natural menopause before age 40. Depression can lead to hormonal imbalances, resulting in menstrual disorders and cognitive decline.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Review Pharmacology & Pharmacy

Polypharmacy in schizophrenia

Lone Baandrup

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)

Article Psychiatry

Serum testosterone levels in bipolar and unipolar depressed female patients and the role of medication status

Monica Flores-Ramos et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2020)

Review Computer Science, Interdisciplinary Applications

Development and validation of early warning score system: A systematic literature review

Li-Heng Fu et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2020)

Article Medicine, General & Internal

Bipolar disorders

Roger S McIntyre et al.

LANCET (2020)

Editorial Material Psychiatry

Electroconvulsive Therapy for Treatment-Resistant Schizophrenia

Diarmid J. M. Sinclair et al.

SCHIZOPHRENIA BULLETIN (2019)

Article Pharmacology & Pharmacy

Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study

Anton Pottegard et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Editorial Material Medicine, General & Internal

Schizophrenia

Richard Barnett

LANCET (2018)

Review Psychiatry

Platelet haemostatic function in psychiatric disorders: Effects of antidepressants and antipsychotic drugs

Anna Dietrich-Muszalska et al.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)

Review Clinical Neurology

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies

Brisa Sole et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)

Article Clinical Neurology

Menarche, menstrual problems and suicidal behavior in Chinese adolescents

Hua Chen et al.

JOURNAL OF AFFECTIVE DISORDERS (2017)

Article Psychology, Clinical

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Larry Culpepper et al.

JOURNAL OF CLINICAL PSYCHIATRY (2017)

Article Pediatrics

The Treatment of Dysmenorrhea

Sheryl A. Ryan

PEDIATRIC CLINICS OF NORTH AMERICA (2017)

Article Hematology

Heavy menstrual bleeding: An update on management

Joanna Davies et al.

THROMBOSIS RESEARCH (2017)

Review Obstetrics & Gynecology

The medical management of abnormal uterine bleeding in reproductive-aged women

Linda D. Bradley et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)

Article Pharmacology & Pharmacy

The ergogenic supplement β-hydroxy-β-methylbutyrate (HMB) attenuates insulin resistance through suppressing GLUT-2 in rat liver

Maha H. Sharawy et al.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)

Review Obstetrics & Gynecology

Reproductive and metabolic abnormalities in women taking valproate for bipolar disorder: a meta-analysis

Lin Zhang et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2016)

Article Education, Scientific Disciplines

Heavy menstrual bleeding: work-up and management

Andra H. James

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Article Obstetrics & Gynecology

Obesity and menstrual disorders

Mourad W. Seif et al.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2015)

Article Neurosciences

Pharmacological Approaches for Treatment-resistant Bipolar Disorder

Shi Hui Poon et al.

CURRENT NEUROPHARMACOLOGY (2015)

Article Clinical Neurology

Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials

Yu Hayasaka et al.

JOURNAL OF AFFECTIVE DISORDERS (2015)

Review Neurosciences

Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Shinji Matsunaga et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Review Pharmacology & Pharmacy

The social and economic burden of treatment-resistant schizophrenia: a systematic literature review

James L. Kennedy et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)

Review Psychiatry

Options for Pharmacological Treatment of Refractory Bipolar Depression

Leonardo Tondo et al.

CURRENT PSYCHIATRY REPORTS (2014)

Editorial Material Public, Environmental & Occupational Health

Multivariate or Multivariable Regression?

Bertha Hidalgo et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2013)

Review Hematology

Hemostatic disorders in women

R. A. Kadir et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)

Letter Mathematical & Computational Biology

Letter to the editor

Aristidis K. Nikoloulopoulos

BIOSTATISTICS (2012)

Article Clinical Neurology

No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics

Norio Yasui-Furukori et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2012)

Review Psychiatry

Reproductive and Metabolic Abnormalities Associated with Bipolar Disorder and Its Treatment

Heather A. Kenna et al.

HARVARD REVIEW OF PSYCHIATRY (2009)

Article Endocrinology & Metabolism

Polycystic ovary syndrome in women using valproate: A review

Leonilda Bilo et al.

GYNECOLOGICAL ENDOCRINOLOGY (2008)

Article Pharmacology & Pharmacy

Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder

James Walters et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2008)

Review Biochemistry & Molecular Biology

Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: A review

M. F. Reynolds et al.

CURRENT MEDICINAL CHEMISTRY (2007)

Article Clinical Neurology

Relapse prevention in bipolar disorder: a critical review of current guidelines

RH McAllister-Willams

JOURNAL OF PSYCHOPHARMACOLOGY (2006)

Article Biochemistry & Molecular Biology

Valproate is an anti-androgen and anti-progestin

AK Death et al.

STEROIDS (2005)

Article Clinical Neurology

Longitudinal evaluation of reproductive function in women treated for bipolar disorder

NL Rasgon et al.

JOURNAL OF AFFECTIVE DISORDERS (2005)

Article Clinical Neurology

Reproductive function and risk for PCOS in women treated for bipolar disorder

NL Rasgon et al.

BIPOLAR DISORDERS (2005)

Article Psychiatry

A new instrument for measuring insight: the Beck Cognitive Insight Scale

AT Beck et al.

SCHIZOPHRENIA RESEARCH (2004)